In the present study, we evaluated the effects of apocynin, a potent inhibitor of NADPH oxidase with antioxidant properties, on the mechanisms of muscle atrophy induced by diabetes and concomitant hyperlipidemia. Here, FMO5 is linked to hyperlipidemia.